Agios Pharmaceuticals Inc VE/BAIIA
Quel est le VE/BAIIA de Agios Pharmaceuticals Inc?
Le VE/BAIIA de Agios Pharmaceuticals Inc est N/A
Quelle est la définition de VE/BAIIA?
VE/BAIIA est la valeur de l’entreprise divisée par le bénéfice avant intérêts, impôts, dépréciations et amortissements. Il s'agit d'une mesure du coût d'une action et est plus souvent valable pour des comparaisons entre sociétés que le ratio cours / bénéfice. Il mesure le prix (sous forme de valeur d'entreprise) qu'un investisseur paie au profit des flux de trésorerie de l'entreprise (sous forme de BAIIA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
VE/BAIIA des entreprises dans Health Care secteur sur NASDAQ par rapport à Agios Pharmaceuticals Inc
Que fait Agios Pharmaceuticals Inc?
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
Entreprises avec ve/baiia similaire à Agios Pharmaceuticals Inc
- Perk Labs a VE/BAIIA de N/A
- Canterra Minerals a VE/BAIIA de N/A
- Xortx Therapeutics Inc a VE/BAIIA de N/A
- Comstock Metals Ltd a VE/BAIIA de N/A
- Binovi Technologies a VE/BAIIA de N/A
- RYU Apparel a VE/BAIIA de N/A
- Agios Pharmaceuticals Inc a VE/BAIIA de N/A
- Next Hydrogen Solutions a VE/BAIIA de N/A
- Roots Sustainable Agricultural Technologies a VE/BAIIA de N/A
- Emperor Capital a VE/BAIIA de N/A
- Total Gabon a VE/BAIIA de N/A
- China Uptown a VE/BAIIA de N/A
- Argonaut Resources NL a VE/BAIIA de N/A